Abingworth is a venture capital firm founded in 1973. The firm's headquarters is located in London, United Kingdom, with additional offices in the United States at San Francisco and Boston. As of October 2019, Abingworth has sold off its ownership in 134 companies and is currently managing a portfolio of 25 companies.
Abingworth focuses on funding companies based in Europe and the United States. Sector-wise, Abingworth provides funding for companies in the life sciences industry, with a specific interest in fields such as biotherapeutics, small molecules, nucleic acid therapeutics, and vaccines. For each company, the firm allocates an investment total at a range of $15-$30 million.